VALIANT® Captivia VAMF2424C100TURecalls & reported problems
Medtronic, Inc. · STENT GRAFT VAMF2424C100TU VALCAP FREFL · Class 3 · Implant
All models of VALIANT Captivia (95)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169347113), received between Jan 25, 2017 and Apr 5, 2022 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Defective Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Defective Component1
- Malposition of Device1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- Occlusion1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 5, 2022Defective Component; Defective Component
A VALIANT CAPTIVA STENT GRAFT WAS INTENDED TO BE IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC ULCER. IT WAS REPORTED DURING THE INDEX PROCEDURE, IT WAS NOTED THAT THE DELIVERY SYSTEM HAD A GAP/SEPARATION FROM THE TIP TO THE GRAFT COVER AND IT WOULD NOT SEAL PROPERLY. THE DEVICE WAS NOT IMPLANTED IN THE PATIENT AND A NEW DEVICE WAS USED. PER PHYSICIAN THE CAUSE OF THE GAP WAS DUE TO THE DELIVERY SYSTEM. NO ADDITIONAL CLINICAL SEQUELAE WAS REPORTED AND THE PATIENT IS FINE.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14011318 ↗InjuryJan 25, 2017Malposition of Device; Malposition of Device
A VALIANT CAPTIVIA STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC TRANSECTION DUE TO A MOTOR VEHICLE ACCIDENT. IT WAS REPORTED THAT THE PHYSICIAN UNINTENTIONALLY COVERED THE LEFT SUBCLAVIAN ARTERY. ACCESS WAS GAINED THROUGH THE PATIENT¿S ARM AND A SNORKEL WAS PLACED. IT WAS NOTED THAT A BYPASS WAS NOT AN OPTION DUE TO THE PATIENT¿S INJURIES. THE FINAL ANGIOGRAM SHOWED THE LEFT SUBCLAVIAN AND VERTEBRAL ARTERY WERE FILLING. THE PHYSICIAN STATED THAT THE CAUSE OF THE EVENT WAS DUE TO THE PIGTAIL COMING BACK WITH PARTIAL FILLING OF THE SUBCLAVIAN, WHICH LED TO AN INACCURATE MARK ON THE SCREEN. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Occlusion
MAUDE report 6277811 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page